The market for drugs that target rare diseases is expected to rival big pharma blockbusters in the coming decades.
Advertisement
The Nutshell
Daily News Roundup
Most Recent
Proposals from researchers receiving more than $1 million a year in NIH funding will be carefully picked over to avoid overlap with ongoing research.
The presumed vice-presidential candidate gets a mixed review on science funding and attitudes.
The rise in the amount of federal money requested through research grants is due to a rise in the overall number of applicants.
The presidential bioethics brain trust unveils its draft recommendations on the use of whole genome sequencing in clinical care and research.
A US federal court rules that procedures in which a patient's own stem cells are extracted, manipulated, and reinjected should be regulated by the FDA.
The first full computer model of a single-celled organism mimics the bacterium’s behaviors and paves the way to more complete disease models.
Rather than rely on plant-derived products, biotech companies are engineering bacteria and yeast to produce ingredients for fragrances.
After years of complaints, the European Commission proposes ways to fix its system in an effort to reinvigorate research on the continent.
Peptides extracted from scorpion venom fights off drug-resistant bacterial infections in mice.
Subjects
- cancer
- cell & molecular biology
- culture
- disease/medicine
- ecology
- evolution
- funding
- genetics & genomics
- NIH
- policy
Sub Categories
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
